Compound Kit and Combo Pack Trends in 2018
1 MIN READ
As traditional compound utilization and cost continue to decline, high impact therapeutic categories are emerging to take their place.
Foot and Ankle Injuries including Plantarfascitis [Recording]
Healthy feet are vital for mobility.
Prescription and Private Label Topical Trends in 2018
1 MIN READ
Topicals represent 5.1% of total prescriptions and 14% of total drug cost, and are being prescribed as an alternative to some oral medications.
Cost Drivers & Complex Claims [Recording]
Detailing the volatility, complications and care needs of an injured worker can often be a challenge for insurance professionals.
High Impact Drug Class Trends in 2018
1 MIN READ
Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings.
Beyond the Status Quo
5 MIN READ
We have been conditioned to expect that “best” equates to positive, desired results. Whether in sports, business or healthcare – we strive beyond good or better and desire the “best.” But implementing accepted status quo best practices doesn’t guarantee optimum results. History is scattered with epic examples of “best” induced stagnation or worse outcomes.
Medication-Assisted Treatment (MAT) Trends in 2018
1 MIN READ
Opioid dependence and abuse are prevalent and continue to be a concern in our society and the workers’ compensation population. Medication-assisted treatment using methadone, buprenorphine, or naltrexone along with counseling and other support is one of the options for managing opioid use disorder. Analyzing the trends within our data related to these types of medications can provide valuable additional insight into the prevalence of evidence-based and guideline-supported approaches related to overall opioid strategy.